Viewing StudyNCT00460811



Ignite Creation Date: 2024-05-05 @ 5:30 PM
Last Modification Date: 2024-10-26 @ 9:32 AM
Study NCT ID: NCT00460811
Status: COMPLETED
Last Update Posted: 2013-02-04
First Post: 2007-04-13

Brief Title: Randomized Double-blind Dose-range-finding Phase 2 Study of Linaclotide Administered to Patients With Irritable Bowel Syndrome With Constipation IBS-C
Sponsor: Ironwood Pharmaceuticals Inc
Organization: Ironwood Pharmaceuticals Inc

Conditions & Keywords Data

Conditions:
Name
Irritable Bowel Syndrome With Constipation
Keywords:
Name View
Irritable Bowel Syndrome with Constipation View
IBS View
Irritable Bowel Syndrome View
linaclotide acetate View
linaclotide View
MD-1100 View